Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Geron Corp (NASDAQ:GERN)

2.03
Delayed Data
As of Aug 18
 -0.03 / -1.46%
Today’s Change
1.81
Today|||52-Week Range
3.15
-1.93%
Year-to-Date

Today’s Trading

Previous close2.06
Today’s open2.03
Day’s range1.99 - 2.06
Volume818,152
Average volume (3 months)1,462,696
Market cap$323.2M
Dividend yield--
Data as of 4:00pm ET, 08/18/2017

Growth & Valuation

Earnings growth (last year)-63,433.33%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)-83.06%
P/E ratioNM
Price/Sales53.43
Price/Book2.64

Competitors

 Today’s
change
Today’s
% change
BCRXBioCryst Pharmaceuti...0.000.00%
EDGEEdge Therapeutics In...+0.15+1.42%
AGENAgenus Inc+0.06+1.71%
SELBSelecta Biosciences ...-0.78-4.87%
Data as of 4:00pm ET, 08/18/2017

Financials

Next reporting dateNovember 9, 2017
EPS forecast (this quarter)-$0.05
Annual revenue (last year)$6.2M
Annual profit (last year)-$29.5M
Net profit margin-479.34%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
John A. Scarlett
Chief Financial Officer, Treasurer &
Executive VP
Olivia K. Bloom
Corporate headquarters
Menlo Park, California

Forecasts